Bray M - Search Results

1

Bradfute SB, Warfield KL, Bray M. Bradfute SB, et al. Among authors: bray m. Viruses. 2012 Sep;4(9):1477-508. doi: 10.3390/v4091477. Epub 2012 Sep 7. Viruses. 2012. PMID: 23170168 Free PMC article. Review.

2

Filovirus infection of STAT-1 knockout mice.

Raymond J, Bradfute S, Bray M. Raymond J, et al. Among authors: bray m. J Infect Dis. 2011 Nov;204 Suppl 3:S986-90. doi: 10.1093/infdis/jir335. J Infect Dis. 2011. PMID: 21987780

3

Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.

Ayithan N, Bradfute SB, Anthony SM, Stuthman KS, Dye JM, Bavari S, Bray M, Ozato K. Ayithan N, et al. Among authors: bray m. J Interferon Cytokine Res. 2014 Feb;34(2):79-89. doi: 10.1089/jir.2013.0035. Epub 2013 Oct 8. J Interferon Cytokine Res. 2014. PMID: 24102579 Free PMC article.

4

Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.

Bradfute SB, Anthony SM, Stuthman KS, Ayithan N, Tailor P, Shaia CI, Bray M, Ozato K, Bavari S. Bradfute SB, et al. Among authors: bray m. PLoS One. 2015 Mar 18;10(3):e0118434. doi: 10.1371/journal.pone.0118434. eCollection 2015. PLoS One. 2015. PMID: 25785602 Free PMC article.

5

Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection.

Ayithan N, Bradfute SB, Anthony SM, Stuthman KS, Bavari S, Bray M, Ozato K. Ayithan N, et al. Among authors: bray m. PLoS One. 2015 Feb 26;10(2):e0118345. doi: 10.1371/journal.pone.0118345. eCollection 2015. PLoS One. 2015. PMID: 25719445 Free PMC article.

6

Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.

Chang TH, Kubota T, Matsuoka M, Jones S, Bradfute SB, Bray M, Ozato K. Chang TH, et al. Among authors: bray m. PLoS Pathog. 2009 Jun;5(6):e1000493. doi: 10.1371/journal.ppat.1000493. Epub 2009 Jun 26. PLoS Pathog. 2009. PMID: 19557165 Free PMC article.

7

Small Animal Models for Studying Filovirus Pathogenesis.

Yamaoka S, Banadyga L, Bray M, Ebihara H. Yamaoka S, et al. Among authors: bray m. Curr Top Microbiol Immunol. 2017;411:195-227. doi: 10.1007/82_2017_9. Curr Top Microbiol Immunol. 2017. PMID: 28653189 Review.

8

Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.

Jones SM, Stroher U, Fernando L, Qiu X, Alimonti J, Melito P, Bray M, Klenk HD, Feldmann H. Jones SM, et al. Among authors: bray m. J Infect Dis. 2007 Nov 15;196 Suppl 2:S404-12. doi: 10.1086/520591. J Infect Dis. 2007. PMID: 17940977

9

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.

Huggins J, Zhang ZX, Bray M. Huggins J, et al. Among authors: bray m. J Infect Dis. 1999 Feb;179 Suppl 1:S240-7. doi: 10.1086/514316. J Infect Dis. 1999. PMID: 9988190

10

Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient.

Bausch DG, Feldmann H, Geisbert TW, Bray M, Sprecher AG, Boumandouki P, Rollin PE, Roth C; Winnipeg Filovirus Clinical Working Group. Bausch DG, et al. Among authors: bray m. J Infect Dis. 2007 Nov 15;196 Suppl 2:S136-41. doi: 10.1086/520542. J Infect Dis. 2007. PMID: 17940941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

614 results

Search Page